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Since 1990 the World Health Organi-
zation uses the disability-adjusted life year
(DALY) statistic to quantify the burden of
diseases [1]. This indicator quantifies in
one measure both the morbidity and the
mortality due to disease. Estimating
DALYs is intrinsically problematic since
for some conditions only limited data are
available [1,2]. For several tropical diseas-
es, especially those affecting people in the
poorest countries, it has been argued that
DALYs are systematically underestimated
[1–3]. Because it is considered economi-
cally unprofitable, virtually no new drugs
are being developed for this group of
conditions [4,5]. Being underestimated
and lacking targeted drug development
programs, these conditions have been
termed neglected tropical diseases (NTDs).
The list of infections that are considered to
be NTDs varies depending on the au-
thor(s). However, they are usually taken to
include those listed in Table 1 together
with dracunculiasis and Buruli ulcer.
Although there may be room for
improvement in the calculation of DALYs
related to NTDs, governments and policy
makers use them to determine priorities in
prevention and health care and therefore
they cannot be ignored. Following Swin-
gler et al. [6], research efforts targeted at a
disease should ideally be in proportion to
its global health impact. However, NTDs
are prone to be less considered by the
scientific community than what their
DALYs would call for. Therefore, it
appeared worthwhile to investigate wheth-
er NTDs are not neglected twice: once by
being attributed an underestimated DALY
and again by limited scientific attention.
Indicators of Scientific Interest
We did not include all diseases that are
considered NTDs in our analysis, because
only 13 of them are listed in the DALY
estimates published by WHO [7]. For
these 13 NTDs, 13 other non-NTD
conditions with matched estimated
DALYs (Table 1) were selected for search-
es of the scientific literature. The matched
diseases were chosen on the basis of two
criteria: (1) the disease had to be listed as a
separate condition in the DALY estimates
and (2) we chose the condition with the
closest matching DALY. The DALYs
associated with each group of conditions
did not differ significantly based on a
paired Wilcoxon signed rank test and a
paired t-test after log transformation of the
DALYs (in both cases, pw0:1).
We queried both the freely available
PubMed database and the ISI Web of
Science database to determine the number
of publications for each disease per year
since 1970. These two databases comple-
ment each other and using both of them is
likely to give a more balanced image of
research efforts. The Web of Science is
more extensive, listing publications from
many fields of science, and contains over
85 million records. PubMed contains
fewer records (about 19 million) but has
better coverage of older publications [8].
In both databases the disease name as
listed in Table 1 was entered as a search
term.
Our analysis shows that NTDs are less
researched than the matched conditions
with comparable DALYs (Figure 1). More-
over, the gap has widened during recent
years. Averaged across time, the number
of papers on the matched conditions was
four times higher in the PubMed database
and six times higher in Web of Science.
However, around 2003–2004, when the
discrepancy between the number of papers
published for each group of conditions was
the largest, the number of papers pub-
lished on NTDs was five (PubMed) to
eight (Web of Science) times lower than on
conditions with similar estimated impact.
In line with these findings, the number
of reviews in PubMed on NTDs was lower
than for the matched diseases (Figure 1).
The number of reviews on a condition is
considered important for clinical practice
[6]. Previously it was found that the
number of systematic reviews on diseases
is moderately correlated with their as-
signed DALYs and that this correlation
holds for both the established market
economies as well as for the global disease
impact [6]. Contradicting this observation,
we found that the number of reviews in
PubMed on NTDs was much lower than
for the matched diseases. Therefore,
focusing on the neglected diseases and
matched counterparts reveals a discrepan-
cy that has gone unnoticed by aggregating
many diseases.
Although there was considerable vari-
ance between the disease pairs, for all but
one NTD-matched condition pair the
matched disease attracted more research.
This did not hold for polio and leprosy (see
Figure 1D). More papers were published
on leprosy than on polio in the period
1970–2009. We accounted for this in two
ways. First, polio and leprosy constitute
the worst matched disease pair. The
estimated impact of leprosy is more than
five times higher than that of polio.
However, no better matching disease was
available for leprosy. Second, poliomeylitis
has been eradicated in many developed
areas in the world, which might reduce the
incentive for carrying out research on this
topic.
The difference in scientific output
between NTDs and the matched condi-
tions is higher for the Web of Science than
for PubMed. This is due to both a lower
number of publications on NTDs and a
slightly higher number of publications on
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The Web of Science lists only research
published in well-established journals. It is
known that research on NTDs is less likely
to be featured in such journals [9]. This
stresses the importance of targeted jour-
nals on NTDs such as PLoS Neglected
Tropical Diseases.
The disproportionally low research inter-
e s ti nN T D si sd o u b l yw o r r y i n gi fo n e
considers that the DALYs associated with
N T D sa r eg e n e r a l l ya s s u m e dt ob eu n d e r -
estimated. For example, Hotez et al. [10] list
updated estimates for the DALYs associated
with several NTDs (see also Table 1). These
updated estimates clearly indicate that their
real impact on health and quality of life
worldwide may actually be considerably
higher than that of the matched conditions.
Indicators of Public Interest
The Google internet search engine
provides access to the search volume for
Table 1. The NTDs and the matched conditions included in the study.
Neglected Tropical Disease DALY, WHO 2004 DALY, Hotez et al. 2006 [10] Matched Condition DALY, WHO 2004
Leprosy 194 200 Poliomyelitis 34
Onchocerciasis 388 500 Diphtheria 173
Chagas disease 430 700 Periodontal disease 320
Dengue 670 N/A Appendicitis 418
Japanese encephalitis 681 N/A Vitamin A deficiency 629
Trichuriasis 1,012 6,400 Hepatitis C 954
Hookworm disease 1,091 22,100 Bladder cancer 1,451
Trachoma 1,334 2,300 Otitis media 1,488
Trypanosomiasis 1,673 1,500 Multiple sclerosis 1,527
Schistosomiasis 1,707 4,500 Parkinson disease 1,710
Ascariasis 1,851 10,500 Ovary cancer 1,745
Leishmaniasis 1,974 2,100 Hepatitis B 2,067
Filariasis 5,940 5,800 Tetanus 5,283
Mean 1,457 5,145 Mean 1,369
The reported DALYs were taken from WHO 2004 estimates [7]. Estimated DALYs for the NTDs by Hotez et al. [10] are also included for comparison (see text for details).
The listed DALYs have all been scaled by a factor 1/1,000.
doi:10.1371/journal.pntd.0000576.t001
Figure 1. Number of publications on NTDs and matched conditions. (A) The number of publications in PubMed and Web of Science as a
function of time for the NTDs and the matched conditions. (B) The ratio between the number of publications in PubMed and Web of science on NTDs
and the matched conditions as a function of time. The lines are spline smoothed versions of the ratio data. (C, D) Idem as (A, B) but for the reviews
found in the PubMed database. (E) The ratios of the estimated DALYs and number of publications for each NTD-matched condition pair summed
across time. The vertical lines indicate a ratio of 1, 2, 4 and 6 respectively. Notice that the x-axis has a logarithmic scaling.
doi:10.1371/journal.pntd.0000576.g001
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Trends application. For each disease name
we extracted the proportion of queries
processed by Google from 2004 to present.
The number of Web pages found by
Yahoo on NTDs and the matched condi-
tions was also retrieved.
We also found that on the internet less
information about NTDs is available to
the public. Additionally, this information is
also accessed less often. Indeed, the
number of internet searches processed by
Google in the period 2004–2009 was 2.25
times lower for NTDs than for the
matched conditions. Similarly, the number
of Web pages found by Yahoo on NTDs
was lower than for the matched conditions
(Wilcoxon signed rank test, pv0:05). This
indicates that the lack in research interest
in NTDs is sustained by a lack in public
interest as well.
Changing Tides?
There are preliminary indications that
there now is an increased interest in
NTDs. The use of the term ‘‘neglected
tropical disease’’ has, across both databas-
es, risen monotonically since 2004 (the first
item we found on the topic was an
editorial by Holland in 1991 [11], which
appeared in the Web of Science). The
number of records mentioning neglected
tropical diseases has risen from one in
PubMed and four in the Web of Science in
2005 to 32 and 69, respectively, in 2008.
This increase is mostly due to articles
published in PLoS Neglected Tropical Diseases.
An increase in internet queries on NTDs
was observed as well. In 2004, matched
diseases were queried 3.3 times as often as
NTDs. In the first half of 2009 this ratio
dropped to 1.8.
Moreover, the ratio between the num-
ber of publications of the two groups of
diseases reached its peak in 2003–2004.
Since then, the ratio seems to be falling.
This finding is in concordance with the
recent increase in research effort targeted
at drug development for NTDs [12].
Indeed, new international initiatives may
further contribute significantly toward
reducing the so-called 10/90 gap. The
10/90 gap concept refers to the finding
that only 10% or less of the global
expenditure on medical research and
development is directed toward neglected
health problems [13].
The recent increase in academic and
public interest in NTDs are important
indicators of change. These and other
indications of a turning tide need to be
confirmed in the future. It should also be
noted that, even when research effort into
NTDs would, in a few years from now,
match that of diseases with equal impact,
there still is a need to pay off the arrears of
the past (see Figure 1D). Similarly, al-
though it has been argued that the
increase in the number of drug develop-
ment programs is a step in the right
direction, the efforts are still too small to
change the situation profoundly [5]. Also,
the current paucity of research on NTDs
might slow down the readjustment of their
DALYs.
More research is needed in order to
gain a more realistic estimate of the
burden of these diseases; the resulting
higher estimates of DALYs would proba-
bly cause these diseases to attract more
research. By the same token, a lack of
attention to these diseases could be self-
perpetuating. It will be necessary for civil
society, scientists, and policymakers alike
to break this cycle so that some of the most
common infections among the 2.7 billion
people living on less than US$ 2 per day
[3], receive the attention they deserve.
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